Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest update is out from TC Biopharm (Holdings) Plc Sponsored ADR ( (TCBP) ).
TC BioPharm conducted a general meeting on December 30, 2024, where all proposed resolutions were passed. Key resolutions included authorizing the capitalization and distribution of bonus shares, allotment of shares up to £50,000,000, and allotment of equity securities for cash without pre-emption rights, which are expected to enhance the company’s strategic flexibility and financial position.
More about TC Biopharm (Holdings) Plc Sponsored ADR
TC BioPharm (Holdings) Plc is a biotechnology company based in Scotland, United Kingdom, specializing in the development and commercialization of cell-based immunotherapies for the treatment of cancer and infectious diseases. The company focuses on innovative therapies within the biopharmaceutical industry.
YTD Price Performance: -97.76%
Average Trading Volume: 1,738,565
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $351.1K
For a thorough assessment of TCBP stock, go to TipRanks’ Stock Analysis page.
